The interaction between cucurbit[8]uril and baicalein and the effect on baicalein properties
Xiaodong Zhang1, Jun Xie1, Zhiling Xu1
1Key Laboratory of Macrocyclic and Supramolecular Chemistry of Guizhou Province, Guizhou University, Guiyang 550025, China.
Baicalein (BALE) forms a 1:1 inclusion complex with cucurbit[8]uril (Q[8]). This host-guest interaction alters the chemical properties of baicalein, as confirmed by spectroscopic and thermal analyses.
Area of Science:
- Supramolecular Chemistry
- Host-Guest Chemistry
- Chemical Spectroscopy
Background:
- Baicalein is a natural flavonoid with potential therapeutic properties.
- Cucurbit[8]uril is a macrocyclic host molecule known for its ability to form inclusion complexes.
- Understanding host-guest interactions is crucial for developing new drug delivery systems and modifying compound properties.
Purpose of the Study:
- To investigate the host-guest interactions between baicalein (BALE) and cucurbit[8]uril (Q[8]).
- To characterize the inclusion complex formed between BALE and Q[8].
- To determine how Q[8] influences the properties of BALE.
Main Methods:
- Proton Nuclear Magnetic Resonance (1H NMR) spectroscopy
- Infrared (IR) spectroscopy
- Ultraviolet-visible (UV-vis) spectroscopy
- Differential Thermal Analysis (DTA)
Main Results:
- Evidence of a 1:1 inclusion complex formation between BALE and Q[8].
- Spectroscopic data indicate significant changes in BALE's properties upon complexation.
- DTA results further support the formation and stability of the inclusion compound.
Conclusions:
- Baicalein forms a stable 1:1 inclusion compound with cucurbit[8]uril.
- Cucurbit[8]uril effectively modifies the properties of baicalein through host-guest interactions.
- This complexation could have implications for baicalein's bioavailability and therapeutic applications.
More Related Videos
05:59Author Spotlight: Advancing Antimicrobial Resistance Research with Innovative Approaches and Synthetic Compounds
Published on: September 27, 2024
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
